Mega menu

Home
Product regulation
Product regulation

Understand your obligations and access industry Guidance and other information about the products we regulate.
Safety and shortages
Safety and shortages

Access information about product recalls, shortages and other alerts, and learn how we manage safety.
Resources and guidance
Resources and guidance

Get information to help you understand our work, regulations and industry obligations.
Business services
Business services

Access our systems to submit applications, manage forms, make payments and communicate securely.

Dr Reddys Laboratories Australia Pty Ltd

Regulatory activities for this sponsor.

- LinkedIn
- (Twitter)
- Facebook
- Email

Loading...

Type

Cancellation by sponsor (319)
ARTG (289)
Prescription medicine registration (28)
Designation or determination (2)
Prescription medicine evaluation (2)

Date

2026 (39)
2025 (30)
2024 (51)
2023 (161)
2022 (30)
2021 (55)
2020 (45)
2019 (26)
2018 (50)
2017 (35)
2016 (77)
2015 (2)
2014 (1)
2013 (9)
2012 (10)
2011 (2)
2010 (10)
2008 (2)
2002 (2)
2001 (3)

Search

Sponsor content

640 result(s) found, displaying 561 to 570

LISINOPRIL-DRLA lisinopril 2.5mg (as dihydrate) tablet blister pack Cancelled under Section 30(1)(c) of the Act

29 March 2018

Cancellation by sponsor

Requested by Dr Reddys Laboratories Australia Pty Ltd
LISINOPRIL-DRLA lisinopril 5mg (as dihydrate) tablet blister pack Cancelled under Section 30(1)(c) of the Act

29 March 2018

Cancellation by sponsor

Requested by Dr Reddys Laboratories Australia Pty Ltd
LISINOPRIL-DRLA lisinopril 10mg (as dihydrate) tablet blister pack Cancelled under Section 30(1)(c) of the Act

29 March 2018

Cancellation by sponsor

Requested by Dr Reddys Laboratories Australia Pty Ltd
LISINOPRIL-DRLA lisinopril 20mg (as dihydrate) tablet blister pack Cancelled under Section 30(1)(c) of the Act

29 March 2018

Cancellation by sponsor

Requested by Dr Reddys Laboratories Australia Pty Ltd
BORTEZOMIB-REDDY'S; BORTEZOMIB-DRLA; BORTEZOMIB-RZ (Dr Reddys Laboratories Australia Pty Ltd)

8 March 2018

Prescription medicine registration

Active ingredients: Bortezomib.
AMCAL FEXO 180 fexofenadine hydrochloride 180 mg film coated tablet blister pack (223782)

26 May 2014

ARTG

Australian Register of Therapeutic Goods (ARTG) information for AMCAL FEXO 180 fexofenadine hydrochloride 180 mg film coated tablet blister pack.
Calcium GH Cancelled under s30(1)(c)

30 June 2017

Cancellation by sponsor

Requested by Dr Reddys Laboratories Australia Pty Ltd
HAYFEXO fexofenadine hydrochloride 120 mg film coated tablet blister pack Cancelled under s30(1)(c)

30 June 2017

Cancellation by sponsor

Requested by Dr Reddys Laboratories Australia Pty Ltd
PHARMACY HEALTH CETIRIZINE cetirizine hydrochloride 10mg film coated tablet blister pack Cancelled under s30(1)(c)

30 June 2017

Cancellation by sponsor

Requested by Dr Reddys Laboratories Australia Pty Ltd
PHARMACY HEALTH fexofenadine hydrochloride 120mg film-coated tablet blister pack Cancelled under s30(1)(c)

30 June 2017

Cancellation by sponsor

Requested by Dr Reddys Laboratories Australia Pty Ltd

Pages

First page
Previous page
…
Page 53
Page 54
Page 55
Page 56
Current page 57
Page 58
Page 59
Page 60
Page 61
…
Next page
Last page

Using our website

Accessibility
Privacy
Security
Disclaimer
Copyright
Freedom of information
Acronyms and glossary terms

Quick links

Search our databases
Report a problem or side effect
TGA Business Services
Special Access Scheme
Authorised Prescriber
Office of Drug Control
State and territory contacts

Connect with us

Email subscriptions
Contact us
Facebook
(formerly Twitter)
Youtube
Instagram
LinkedIn

Help us improve

We are always looking for ways to improve our website.

Provide feedback

The Department of Health, Disability and Ageing acknowledges First Nations peoples as the Traditional Owners of Country throughout Australia, and their continuing connection to land, sea and community. We pay our respects to them and their cultures, and to all Elders both past and present.